Working... Menu

Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (SHINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03487276
Recruitment Status : Active, not recruiting
First Posted : April 4, 2018
Last Update Posted : December 5, 2018
Quintiles, Inc.
Information provided by (Responsible Party):
InflaRx GmbH

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : October 2019